Modernize Precision Oncology With Decentralized Trial Tools

Muhammad Shaalan Beg; Vivek Subbiah

doi:10.1001/jamaoncol.2023.6786

Modernize Precision Oncology With Decentralized Trial Tools

JAMA Oncol. 2024 Apr 1;10(4):427-428. doi: 10.1001/jamaoncol.2023.6786.

Authors

Muhammad Shaalan Beg^{1

2}, Vivek Subbiah³

Affiliations

¹ Division of Hematology and Oncology, UT Southwestern Medical Center, Dallas, Texas.
² Science 37 Inc, Durham, North Carolina.
³ Sarah Cannon Research Institute, Nashville, Tennessee.

PMID: 38358775
DOI: 10.1001/jamaoncol.2023.6786

No abstract available

Plain language summary

This Viewpoint examines how modern precision oncology clinical trials, bolstered by decentralized trial tools, can enhance access to cancer treatments and reduce the burden of trial participation on clinics and participants.

MeSH terms

Humans
Medical Oncology
Neoplasms*
Precision Medicine